Runx genes are direct targets of Scl/Tall in the yolk sac and fetal liver

Blood

Volumn 111, Issue 6, 2008, Pages 3005-3014

  Landry, Josette Renée ^a   Kinston, Sarah ^a   Knezevic, Kathy ^a   De Bruijn, Marella F T R ^b   Wilson, Nicola ^a   Nottingham, Wade T ^b   Peitz, Michael ^c   Edenhofer, Frank ^c   Pimanda, John E ^a   Ottersbach, Katrin ^a   Göttgens, Berthold ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR LMO2; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; GATA2 PROTEIN, MOUSE; LMO2 PROTEIN, MOUSE; METALLOPROTEIN; ONCOPROTEIN; RUNX1 PROTEIN, MOUSE; RUNX3 PROTEIN, MOUSE; TAL1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; E BOX ELEMENT; FETUS LIVER; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; RUNX GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION; YOLK SAC; ANIMAL; CELL SEPARATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PRENATAL DEVELOPMENT; SEQUENCE ALIGNMENT;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CELL SEPARATION; CONSERVED SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA-BINDING PROTEINS; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LIVER; METALLOPROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT; YOLK SAC;

EID: 42449101777     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-07-098830     Document Type: Article

References (72)

1. McGrath KE, Palis J. Hematopoiesis in the yolk sac: more than meets the eye. Exp Hematol. 2005;33:1021-1028.
2. Palis J, Yoder MG. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp Hematol. 2001;29:927-936.
3. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996;86:897-906.
4. Kumaravelu P Hook L Morrison AM, et al. Quantitative developmental anatomy of definitive haematopoietic stem cells/long-term repopulating units (HSC/RUs): role of the aorta-gonadmesonephros (AGM) region and the yolk sac in colonisation of the mouse embryonic liver. Development. 2002;129:4891-4899.
5. Samokhvalov IM, Samokhvalova Nl, Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature. 2007;446: 1056-1061.
6. Robb L. Lyons I. Li R. et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A. 1995;92:7075-7079.
7. Shivdasani RA. Mayer EL. Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 1995;373: 432-434.
8. Visvader JE, Fujiwara Y, Orkin SH. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 1998;12:473-479.
9. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ. Rabbitts TH. The oncogenic cysteinerich LIM domain protein rbtn2 is essential for erythroid development. Cell. 1994;78:45-57.
10. Yamada Y Pannell R, Forster A, Rabbitts TH. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A. 2000;97:320-324.
11. Patterson LJ, Gering M, Eckfeldt CE, et al. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood. 2007;109:2389-2398.
12. Wadman IA, Osada H, Grutz GG, et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid. DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 1997;16:3145-3157.
13. Anguita E, Hughes J, Heyworth C, Blobel GA, Wood WG, Higgs DR. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J. 2004;23:2841-2852.
14. Lecuyer E, Herblot S, Saint-Denis M, et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood. 2002;100:2430-2440.
15. Vitelli L, Condorelli G, Lulli V, et al. Apentamer transcriptional complex including tal-1 and retinoblastoma protein down modulates c-kit expression in normal erythroblasts. Mol Cell Biol. 2000;20: 5330-5342.
16. Palomero T Odom DT O'Neil J, et al. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood. 2006;108:986-992.
17. Pimanda JE, Donaldson I J, de Bruijn MR et al. The SCLtranscriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Proc Natl Acad Sci U S A. 2007;104:840-845.
18. Choi K, Kennedy M, KazarovA, Papadimitriou JG, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998; 125:725-732.
19. Thalmeier K, Meissner R Reisbach G, Falk M. Brechtel A, Dormer P. Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood. 1994;83:1799-1807.
20. Ottersbach K, Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell. 2005:8:377-387.
21. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc Natl Acad Sci U S A. 2002;99:4489-4494.
22. Donaldson IJ, Gottgens B. CoMoDis: composite motif discovery in mammalian genomes. Nucleic Acids Res. 2007;35:e1.
23. Forsberg EC, Downs KM, Bresnick EH. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. Blood. 2000;96:334-339.
24. Nottingham WT. Jarratt A, Burgess M, et al. Runx1-mediated hematopoietic stem cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood. 2007;110:4188-4197.
25. Klotz L. Dani I. Edenhofer F, et al. Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. J Immunol. 2007:178: 2122-2131.
26. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med. 2003;9:1428-1432.
27. Nolden L, Edenhofer F, Haupt S, et al. Sitespecific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods. 2006;3:461-467.
28. Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development. 1999; 126:4603-4615.
29. Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TL R3/TLR4-specific antiviral gene program. Immunity. 2002;17:251-263.
30. Lund S, Christensen KV. Hedtjarn M, et al. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006; 180:71-87.
31. Magder S, Neculcea J, Neculcea V, Sladek R. Lipopolysaccharide and TNF-alpha produce very similar changes in gene expression in human endothelial cells. J Vase Res. 2006;43:447-461.
32. Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG. Saban R. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics. 2001;5:147-160.
33. Saban MR, Saban R, Hammond TG, et al. LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol. 2002;282: F202-F210.
34. Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND. Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol. 2007;8:1.
35. Donaldson IJ, Chapman M, Kinston S, etal. Genome-wide identification of cis-regulatory sequences controlling blood and endothelial development. Hum Mol Genet. 2005;14:595-601.
36. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321-330.
37. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck N A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 1996;93: 3444-344g.
38. Kalev-Zylinska ML, Horsfield JA, Flores MV, et al. Runx3 is required for hematopoietic development in zebrafish. Dev Dyn. 2003;228:323-336.
39. Levanon D, Groner Y Structure and regulated expression of mammalian RUNX genes. Oncogene. 2004;23:4211-4219.
40. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21:3368-3376.
41. Enver T, Greaves M. Loops, lineage, and leukemia. Cell. 1998;94:9-12.
42. Gottgens B, Green AR. Transcriptional regulation of hematopoietic stem cells. In: Lanza HMB, Melton DA. et al, ed. Handbook of Stem Cells: Amsterdam, the Netherlands: Elsevier Academic Press; 2004.
43. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89-101.
44. Faloon P, Arentson E, KazarovA, et al. Basic fibroblast growth factor positively regulates hematopoietic development. Development. 2000;127: 1931-1941.
45. Robertson SM, Kennedy M, Shannon JM, Keller G. Atransitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 2000;127:2447-2459.
46. Gering M, RodawayAR, Gottgens B, Patient RK, Green AR. The SCL gene specifies hemangioblast development from early mesoderm. EMBO J. 1998;17:4029-4045.
47. Gottgens B, Broccardo C, Sanchez MJ, et al. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. Mol Cell Biol. 2004;24:1870-1883.
48. Gottgens B, Nastos A, Kinston S, et al. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J. 2002;21:3039-3050.
49. Sanchez M, Gottgens B, Sinclair AM, et al. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development. 1999;126:3891-3904.
50. Silberstein L, Sanchez MJ, Socolovsky M, et al. Transgenic analysis of the stem cell leukemia + 19 stem cell enhancer in adult and embryonic hematopoietic and endothelial cells. Stem Cells. 2005;23:1378-1388.
51. Delabesse E, Ogilvy S, Chapman MA, Piltz SG, Gottgens B. Green AR. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo. Mol Cell Biol. 2005:25:5215-5225.
52. DeleuzeV, Chalhoub E, El-Hajj R, et al. TAL-1/SCL and its partners E47 and LM02 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol. 2007:27:2687-2697.
53. Khandekar M, Brandt W, Zhou Y, et al. AGata2 intronic enhancer confers its pan-endothelia-specific regulation. Development. 2007;134:1703-1712.
54. Lahlil R, Lecuyer E, Herblot S, Hoang T. SCL assembles a multifactorial complex that determines glycophorin A expression. Mol Cell Biol. 2004;24: 1439-1452.
55. Xu Z, Huang S, Chang LS, Agulnick AD, Brandt SJ. Identification of aTAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol. 2003:23:7585-7599.
56. Lacaud G, Gore L, Kennedy M, et al. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood. 2002:100:458-466.
57. Tsai FY Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 1997;89:3636-3643.
58. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol. 1999; 31:1037-1051.
59. Ito Y. Oncogenic potential of the RUNX gene family: overview. Oncogene. 2004;23:4198-4208.
60. North T, Gu TL, Stacy T, et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 1999;126:2563-2575.
61. North TE, de Bruijn MF, Stacy T, et al. Runxl expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 2002;16:661-672.
62. Fainaru O, Woolf E, Lotem J, et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 2004;23:969-979.
63. Shi MJ, Stavnezer J. CBF alpha3 (AML2) is induced by TGF-betal to bind and activate the mouse germline Ig alpha promoter. J Immunol. 1998;161:6751-6760.
64. Inoue K, Ozaki S, Shiga T, et al. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci. 2002;5:946-954.
65. Levanon D, Bettoun D, Harris-Cerruti C, et al. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 2002;21:3454-3463.
66. Taniuchi I, Osato M, Egawa T, et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 2002;111:621-633.
67. Woolf E, Xiao C, Fainaru O, et al. Runx3 and Runxl are required for GD8 T cell development during thymopoiesis. Proc Natl Acad Sci U S A. 2003;100:7731-7736.
68. Otto F, Lubbert M, Stock M. Upstream and downstream targets of RUNX proteins. J Cell Biochem. 2003;89:9-18.
69. Spender LC, Whiteman HJ, Karstegl CE, Farrell PJ. Transcriptional cross-regulation of RUNX1 by RUNXS in human B cells. Oncogene. 2005;24: 1873-1881.
70. Patterson LJ, Gering M, Patient R. Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood. 2005;105: 3502-3511.
71. Reynaud D, Ravet E, Titeux M, et al. SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood. 2005;106:2318-2328.
72. Huss R, Heil M, Moosmann S, et al. Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL(+) multipotent adult progenitor cell clones from peripheral blood. J Vase Res. 2004;41:422-431.